(Q42513586)

English

The protective action of nefiracetam against electrophysiological and metabolic damage in the hippocampus after deprivation of glucose and oxygen

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The protective action of nefiracetam against electrophysiological and metabolic damage in the hippocampus after deprivation of glucose and oxygen (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

0 references

electrophysiology

1 reference

based on heuristic

inferred from title

author name string

Aihara H

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Li X

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Fujiwara S

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Matsumura T

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Okumura S

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Tozaki H

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Kanno T

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Ohta K

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Nagai K

9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Nishizaki T

10

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

922

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

158-162

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Effects of nefiracetam on amnesia animal models with neuronal dysfunctions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Adenosine activates the K+ channel and enhances cytosolic Ca2+ release via a P2Y purinoceptor in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

A 'long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Recovery of neuronal activity and high-energy compound level after complete and prolonged brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Neuronal nicotinic receptors: functional correlates of ligand binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Presynaptic nicotinic ACh receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Nefiracetam ameliorates learning deficits in older rabbits and may act via the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Mecamylamine- or scopolamine-induced learning impairment: ameliorated by nefiracetam.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Identifiers

10.1016/S0006-8993(01)03165-1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42513586&oldid=2046700925"